Vanguard Group Inc Organon & Co. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Organon & Co. stock. As of the latest transaction made, Vanguard Group Inc holds 32,277,543 shares of OGN stock, worth $212 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

32,277,543

Previous 29,701,733 8.67%

Holding current value

$212 Million

Previous $442 Million 29.35%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$8.04 - $14.72 $20.7 Million - $37.9 Million	2,575,810 Added 8.67%	32,277,543 $312 Million
Q1 2025 May 09, 2025	SELL	$14.29 - $16.41 $10 Million - $11.5 Million	-699,976 Reduced 2.3%	29,701,733 $442 Million
Q4 2024 Feb 11, 2025	BUY	$14.44 - $18.83 $3.15 Million - $4.11 Million	218,165 Added 0.72%	30,401,709 $454 Million
Q3 2024 Nov 13, 2024	SELL	$18.65 - $23.03 $552,636 - $682,424	-29,632 Reduced 0.1%	30,183,544 $577 Million
Q2 2024 Aug 13, 2024	SELL	$17.45 - $21.96 $10.1 Million - $12.7 Million	-576,674 Reduced 1.87%	30,213,176 $625 Million
Q1 2024 May 10, 2024	BUY	$13.78 - $18.8 $2.65 Million - $3.62 Million	192,613 Added 0.63%	30,789,850 $579 Million
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $9.12 Million - $14.4 Million	-832,896 Reduced 2.65%	30,597,237 $441 Million
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $3.94 Million - $5.65 Million	-237,674 Reduced 0.75%	31,430,133 $546 Million
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $162,754 - $208,024	-8,446 Reduced 0.03%	31,667,807 $659 Million
Q1 2023 Jul 14, 2023	BUY	$21.42 - $32.08 $11,352 - $17,002	530 Added 0.0%	31,676,253 $745 Million
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $4.37 Million - $6.55 Million	204,028 Added 0.65%	31,675,723 $745 Million
Q4 2022 Feb 10, 2023	BUY	$23.31 - $28.61 $28.9 Million - $35.5 Million	1,241,224 Added 4.11%	31,471,695 $879 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $12.6 Million - $18.4 Million	536,373 Added 1.81%	30,230,471 $707 Million
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $17 Million - $20.9 Million	537,681 Added 1.84%	29,694,098 $1 Billion
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $11.6 Million - $15 Million	381,744 Added 1.33%	29,156,417 $1.02 Billion
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $975,152 - $1.26 Million	-34,013 Reduced 0.12%	28,774,673 $876 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $2.96 Million - $3.69 Million	-103,554 Reduced 0.36%	28,808,686 $945 Million
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $823 Million - $1.1 Billion	28,912,240 New	28,912,240 $875 Million

Others Institutions Holding OGN

# of Institutions

793

Shares Held

207M

Call Options Held

2.74M

Put Options Held

1.79M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $1.67B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Organon & Co. Transaction History